RIGL
RIGEL PHARMACEUTICALS INC
RIGEL PHARMACEUTICALS INC (RIGL) has 16 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 11, 2026.
Insiders have net sold $306K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Raul R. Rodriguez
- Employees:172
- HQ:South San Francisco, CA, US
- IPO:2000-11-29
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$306K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$716.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 2,500 | $88K | Jun 24 | SEC ↗ | |
Ali-Jackson KamilFirst filing | Director | Sale | 2,500 | $73K | May 28 | SEC ↗ |
MOOS WALTER HFirst filing | Director | Sale | 4,000 | $145K | Feb 24 | SEC ↗ |
Related companies
RIGEL PHARMACEUTICALS INC is in the Healthcare sector.